147 related articles for article (PubMed ID: 31955649)
21. Interference of polyclonal free light chains with identification of Bence Jones proteins.
Hess PP; Mastropaolo W; Thompson GD; Levinson SS
Clin Chem; 1993 Aug; 39(8):1734-8. PubMed ID: 8353965
[TBL] [Abstract][Full Text] [Related]
22. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.
Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H
Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433
[TBL] [Abstract][Full Text] [Related]
23. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease.
Levinson SS
Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046
[TBL] [Abstract][Full Text] [Related]
24. Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma.
Nowrousian MR; Brandhorst D; Sammet C; Kellert M; Daniels R; Schuett P; Poser M; Mueller S; Ebeling P; Welt A; Bradwell AR; Buttkereit U; Opalka B; Flasshove M; Moritz T; Seeber S
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8706-14. PubMed ID: 16361557
[TBL] [Abstract][Full Text] [Related]
25. kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias.
Levinson SS
Clin Chem; 1991 Jun; 37(6):1122-6. PubMed ID: 1904799
[TBL] [Abstract][Full Text] [Related]
26. Urinary gamma-glutamyl transferase-to-creatinine ratio as an indicator of tubular function in Bence Jones proteinuria.
Yesil EE; Paker N; Yesil A; Kayatas K; Laleli Y; Ari E
Ren Fail; 2014 Apr; 36(3):390-2. PubMed ID: 24392854
[TBL] [Abstract][Full Text] [Related]
27. New patterns of relapse in multiple myeloma: a case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation.
Caldini A; Nozzoli C; Terreni A; Staderini M; Berardi M; Biagioli T; Brogi M; Bosi A
Clin Chem Lab Med; 2016 Jun; 54(6):991-5. PubMed ID: 26581069
[TBL] [Abstract][Full Text] [Related]
28. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies.
Böer K; Deufel T
Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853
[TBL] [Abstract][Full Text] [Related]
29. Urine immunofixation electrophoresis remains important and is complementary to serum free light chain.
Levinson SS
Clin Chem Lab Med; 2011 Nov; 49(11):1801-4. PubMed ID: 21663562
[TBL] [Abstract][Full Text] [Related]
30. Double Bence Jones proteinuria.
Kanoh T; Yago K
Arch Pathol Lab Med; 1990 Sep; 114(9):991-4. PubMed ID: 2117911
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
Wolff F; Thiry C; Willems D
Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
[TBL] [Abstract][Full Text] [Related]
32. Detection of monoclonal free light chains by immunofixation electrophoresis and isoelectric focusing - comparison with the quantitative method of determination.
Kušnierová P; Zeman D; Revendová K; Dlouhý O
Scand J Clin Lab Invest; 2020 Nov; 80(7):556-561. PubMed ID: 32779491
[TBL] [Abstract][Full Text] [Related]
33. Differences identified between serum and urine immunofixation electrophoresis.
Tracy E; Andrews DM; Constantin MA; Zhu Y
Clin Chim Acta; 2015 Jan; 439():68-70. PubMed ID: 25307209
[TBL] [Abstract][Full Text] [Related]
34. Quantification of Free Immunoglobulin Light Chains in Urine.
Singh G; Cotter T; Ye Mon M; Xu H; Bollag RJ
J Appl Lab Med; 2023 Nov; 8(6):1101-1114. PubMed ID: 37725944
[TBL] [Abstract][Full Text] [Related]
35. The significance and predictive value of free light chains in the urine of patients with chronic inflammatory rheumatic disease.
Bramlage CP; Froelich B; Wallbach M; Minguet J; Grupp C; Deutsch C; Bramlage P; Koziolek M; Müller GA
Clin Rheumatol; 2016 Dec; 35(12):2939-2946. PubMed ID: 27734231
[TBL] [Abstract][Full Text] [Related]
36. Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity.
Gigante A; Pellicano C; Leodori G; Napodano C; Vantaggio L; Gulli F; Marino M; Visentini M; Rosato E; Basile U
Clin Exp Immunol; 2021 Aug; 205(2):135-141. PubMed ID: 33934349
[TBL] [Abstract][Full Text] [Related]
37. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
Akar H; Seldin DC; Magnani B; O'Hara C; Berk JL; Schoonmaker C; Cabral H; Dember LM; Sanchorawala V; Connors LH; Falk RH; Skinner M
Amyloid; 2005 Dec; 12(4):210-5. PubMed ID: 16399645
[TBL] [Abstract][Full Text] [Related]
38. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
[TBL] [Abstract][Full Text] [Related]
39. Establishment and validation of serum free light chain reference intervals in an ethnic Chinese population.
Liang YF; Chen WM; Wang QT; Zhai YH; Yang YJ; Liu JY; Levoguer A; Sun WH
Clin Lab; 2014; 60(2):193-8. PubMed ID: 24660530
[TBL] [Abstract][Full Text] [Related]
40. Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass Spectrometry.
Sepiashvili L; Kohlhagen MC; Snyder MR; Willrich MAV; Mills JR; Dispenzieri A; Murray DL
Clin Chem; 2019 Aug; 65(8):1015-1022. PubMed ID: 31171529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]